This primary resistance to treatment is linked to the GIST genotype [36,38,39,43] and is found to be more frequent in KIT exon 9 mutations and in wild-type KIT/PDGFRA GISTs. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.